DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/44f48v/europe) has announced the addition of the "Europe Thalassemia Market Highlights - 2014" report to their offering.
The latest research, 'Europe Thalassemia Market Highlights - 2014', provides thalassemia market analysis, competitive landscape, and thalassemia drug sales forecast for Germany, France, Italy, Spain, and UK.
The research includes Europe (Germany, France, Italy, Spain, and UK) thalassemia market size estimates for 2013, market share forecast for six years to 2019, thalassemia drugs market share, thalassemia drugs sales estimates, thalassemia drugs sales forecast, and thalassemia late stage pipeline products.
Reasons To Buy
- Identify drugs marketed in Europe for treating thalassemia including trade name, molecule name, company, and year of launch.
- Find out estimates for Europe thalassemia market size in 2013, key products and their sales, and how the market and products advanced from 2010. You will benefit from our accurate country and indication level valuation of products and the market.
- What is my competitor's drugs market share in the Europe thalassemia market?
- What are the key molecules in pipeline for thalassemia?
- What is the future of Europe thalassemia market?
- Future thalassemia drugs forecast in Europe
For more information visit http://www.researchandmarkets.com/research/44f48v/europe
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.